Moreover, NLR serves as a predictive factor for cancer‐specific survival, progression‐free survival, and disease‐free survival, showing highly significant hazard ratios of more than 1.61 (95% CI = 1.36–1.91), 1.63 (95% CI = 1.39–1.91), and 2.27 (95% CI = 1.85–2.79), respectively.
1
—
—